Immunovant
Price & Volume
Stats
See more52W Range | $12.72-$29.49 |
Market Cap | $3.9B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.82 |
News
See moreYahoo Finance • 13 days ago
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update
Yahoo Finance • 13 days ago
Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025
Yahoo Finance • 15 days ago
Immunovant Q2 2026 Earnings Preview
About
CEO | Dr. Eric Venker M.D., Pharm.D. |
Address | 320 West 37th Street, New York, NY, United States, 10018 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 362 |
